Biochem Pharma (BCHE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: E. T. who wrote (747)	5/31/2000 11:36:00 PM
From: Spekulatius	Read Replies (1) of 783

The jump is probably caused by the following article: biz.yahoo.com It's a nice writeup and very positive for Biochem even though most investors new that already.However, the author should also have mentioned the Clinichem spinin, which will require some cash and will reduce the earnings somewhat, because the Clinichem part of the development cost will not be reimbursed anymore.This is however already discounted in the "core" earnings numbers given by Biochem in the last quarterly report.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next